Topic: Genomics

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that it will host and webcast its Investor Day in New York City on Thursday...
Shares in AstraZeneca (AZN.L: Quote, Profile, Research), which hit one-month highs this week, have potential to rise further in the near term as...
The 4th Annual Biomarker Discovery and Development Conference features presentations of novel technologies to discover biomarkers, how they are...
TenX Biopharma, Inc. announced that it has re-initiated enrollment in the pivotal Phase III clinical trial assessing zanolimumab treatment for...

Sanofi C.E.O. Talks to Genzyme Investors

Sanofi-Aventis's chief executive, Chris Viehbacher, took his case for a takeover directly to Genzyme's investors in meetings in New York on...
The Czech Republic Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical...
Why Pfizer Can't Cure Cancer - Robert Langreth - Treatments - Forbes: "“For the past decade, the whole thrust has been to find the targets, find...
Bristol-Myers Squibb said Tuesday it had agreed to acquire ZymoGenetics, the maker of a hepatitis C drug the companies were jointly developing, for...

Wyeth 'played up hormone therapy'

Wyeth 'played up hormone therapy': "CHICAGO - DRUGMAKER Wyeth used ghostwriters to play up the benefits and downplay the harm of hormone...
FOXBusiness.com - Bristol-Myers To Buy ZymoGenetics For $735 Million Net Of Cash: "Bristol-Myers Chief Executive Lamberto Andreotti said the...